PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
44.98
ESG score below 80% of Biotechnology median of 58.85. Michael Burry would check for potential stranded assets and regulatory compliance issues.
37.65
Environmental score below 80% of Biotechnology median of 55.05. Michael Burry would check for potential carbon tax exposure and regulatory compliance costs.
45.48
Social score below 80% of Biotechnology median of 60.46. Michael Burry would check for potential boycott risks and regulatory compliance issues.
51.82
Governance score 80-90% of Biotechnology median of 60.82. Martin Whitman would look for hidden agency costs and management entrenchment risks.